GLP-1 Under $500 Per Month: Which Options Actually Stay Under the Cap in 2026?

Which GLP-1 under $500 per month actually passes the all-in test?

An option only “passes” when the medicine, plus any required membership, visits, and other must-pay fees, all stay under $500 a month — measured over a real calendar month, not a 28-day supply.

FDA-approved options

Cash / self-pay prices verified against each provider's official pricing pages, July 17, 2026. “Real monthly cost” converts every 28-day fill to a calendar-month number. These are medication prices; a prescriber or telehealth fee is separate.

Compounded options — not FDA-approved

Compounded semaglutide and tirzepatide are commonly advertised at roughly $99–$299 a month, which can undercut brand names. But these prices aren't a clean comparison to the verified rows above: they're not FDA-approved products, the real cost depends on your dose and program, and this market is under active FDA enforcement right now. We cover exactly what that means further down.

Why does a “$449 per month” GLP-1 cost almost $500?

Zepbound and Wegovy injections come in a 28-day supply, not a calendar month. Twenty-eight days doesn't divide evenly into a year, so you need about 13 fills to cover 365 days — not 12. That extra fill quietly raises your true monthly cost. At $449 per 28-day fill, you're really spending about $488 per calendar month, which leaves almost no room for a doctor visit or membership fee.

Supply lengths aren't all the same

Three real-world examples

1. 1Zepbound 7.5 mg, bought direct, no membership: ~$488/month. About $12 of room left before anything else. A fragile pass.
2. 2That same $449 fill plus a hypothetical $40 monthly care fee: ~$488 + $40 = ~$528/month. That fails. The drug was under $500. The total wasn't.
3. 3Wegovy HD at $399 per 28-day fill: ~$434/month. About $66 of room — comfortable, but a recurring fee eats into it fast.

How much room does each route leave for a care fee?

That last column is the whole game. If you're on a low-dose pill, you have hundreds of dollars of room for a full-service telehealth program. If you're on high-dose Zepbound, you have almost none — which decides how you should buy it.

What does a $500 budget unlock that a $300 budget doesn't?

Raising your ceiling from $300 to $500 opens up the standard Wegovy pen, Wegovy HD, more Zepbound doses, and full-service telehealth with brand-name medicine included. The extra room buys you choice — not a reason to overpay. Several strong routes still land well under $300, and if that's your real limit, a lower-priced plan will serve you better.

What jumping from $300 to $500 newly puts on the table:

• Wegovy standard pen and Wegovy HD, straight from the maker.
• Zepbound at 5 mg, and 7.5–15 mg under the refill offer.
• A telehealth membership plus a brand-name pill, all under the cap.
• Real breathing room for a visit or two.

What still might not fit, even at $500:

• Higher-dose Zepbound plus a $149/month platform fee.
• The higher-dose Zepbound price if you miss the refill window (it jumps).
• Cash-pay Ozempic at the 2 mg dose.
• Any program with a big surprise annual prepayment.

Which GLP-1 pills stay under $500 per month?

The two cheapest FDA-approved GLP-1 pills are Foundayo and the Wegovy pill, both starting at $149/month for the lowest dose. Even after you add a telehealth fee through Ro or Sesame, the pill routes usually stay well under $500. Pills are the easiest way in for anyone who hates needles — though injections still deliver the largest average weight loss in trials.

Adding a telehealth program to a pill

Because the pills start so low, they leave plenty of room for a care platform:

Which FDA-approved GLP-1 is cheapest under $500 without insurance?

For pure cash price, Foundayo and the Wegovy pill are the cheapest FDA-approved routes at $149/month for the lowest dose. Zepbound is the cheapest FDA-approved injection at $299/month for the starting dose. Which one is right for you is a separate question — a clinician decides which medicine and dose actually fit your health.

Can Zepbound stay under $500 at every dose?

Yes, at current self-pay prices — but barely at the top. Bought direct from Eli Lilly, Zepbound is $299 to $449 per 28-day fill across all doses. After you convert the higher doses to a real calendar month, they land near $488, which means almost any added membership or visit fee pushes them over $500.

LillyDirect link: not an affiliate, no commission. Ro link: affiliate link; we may earn a commission.

Which telehealth GLP-1 programs stay under $500 after the membership fee?

Ro keeps its Foundayo and Wegovy-pill routes comfortably under $500 with membership included, and its starter-dose Zepbound fits too — but ongoing higher-dose Zepbound on Ro crosses the cap. Sesame's pill routes pass at its lower annual rate. Walgreens can pass with no subscription at all, depending on how often you need visits.

What we checked vs. what to confirm yourself

Which compounded GLP-1 programs stay under $500 — and should you use one?

Many compounded programs advertise $99–$299 a month, which can undercut brand-name prices. But compounded semaglutide and tirzepatide are not FDA-approved, which means the FDA does not review them for safety, quality, or effectiveness before they're sold. In 2026 this market is also under heavy federal enforcement. It can still be a legitimate choice in specific situations, but the price gap has shrunk now that FDA-approved options start at the same $149–$299.

What changed — and why it matters for your wallet and safety

• !The FDA declared the tirzepatide shortage over in October 2024 and the semaglutide shortage over in February 2025. Once a drug leaves the shortage list, the broad legal room to make copies goes away.
• !On April 30, 2026, the FDA proposed removing semaglutide, tirzepatide, and liraglutide from the list of ingredients large compounding facilities are allowed to use. The public comment period runs through July 30, 2026; the outcome is still pending.
• !The FDA sent dozens of warning letters to telehealth companies over misleading compounded-GLP-1 marketing, including a March 2026 action naming 30 companies. The most common problems: implying a compounded drug is the same as the FDA-approved version, or hiding who actually makes it.
• !The FDA has received reports of serious side effects tied to compounded semaglutide and tirzepatide, some requiring hospitalization — often linked to dosing errors when patients measure their own dose from multi-dose vials.

Should you choose compounded just to save money?

Usually not on price alone. In 2024, compounded made obvious sense because the brand names cost $1,000+. In 2026, an FDA-approved pill starts at $149. When the reviewed, approved option costs about the same, the reason to take on compounded's uncertainty gets much thinner.

That said, compounded still has a real lane. A clinician can prescribe a compounded version when an FDA-approved drug won't meet a specific patient's needs and the pharmacy follows the rules. If you're considering it, judge the provider hard. Ask:

• 1What pharmacy actually fills my prescription, and is it named before I pay? (Hiding the source is a red flag the FDA specifically called out.)
• 2Is that pharmacy licensed in my state?
• 3What's the price at my ongoing dose, not just the intro?
• 4Are shipping, supplies, and provider visits included?
• 5What happens if the prescription can't be filled?
• 6How do I cancel, and what's the refund policy?
• 7Is there an active FDA warning letter, recall, or enforcement action tied to this provider?

If a compounded route still fits your situation, Embody is one cash-pay compounded telehealth option readers ask us about — see the full Embody review, and confirm its current medications, pricing, pharmacy source, state availability, and cancellation terms directly before you enroll. Because compounded eligibility is genuinely individual, the smartest move is to let our matching quiz point you to a route that fits your budget and situation rather than guessing.

Can insurance, Medicare, HSA, or FSA get you under $500?

Yes — and if you can, check these first, because they usually beat every cash price. If your commercial plan covers a GLP-1, a savings card can bring an eligible patient's cost to around $25 a fill. If you're on Medicare Part D, a new program offers a flat $50 monthly copay. HSA/FSA is trickier — some manufacturer cash-pay offers actually block reimbursement, so read the terms.

What does a GLP-1 under $500 cost over a full year?

At $500 a month, you're looking at about $6,000 a year — but most people pay less by starting on a lower dose or a cheaper route, and intro offers can cut the first months further. The number that actually matters is your cost at your ongoing maintenance dose, times a full year, after any promotion ends.

• •A $149 pill (lowest dose): about $1,800/year in medication if you stay at that dose. Most people move up, so budget for the higher dose you'll likely land on.
• •Zepbound at $299–$449 per fill: roughly $3,900–$5,850/year in medication, depending on your maintenance dose and the 13-fill effect.
• •A $500/month all-in ceiling: about $6,000/year.

Before you commit, run your maintenance-dose number — not the intro — across a full year, so a temporary price doesn't become a surprise in month four.

How do you verify the real price before you pay?

Confirm six things in writing before you enter your card: the exact medication and dose, how many days it supplies, what you're charged today, what you're charged next time, any refill deadline, and the cancellation terms. A screenshot taken before payment protects you far more than an undated “starting at” price.

Checkout checklist

1. 1The exact drug, and whether it's FDA-approved or compounded.
2. 2The form and dose you'll actually be on.
3. 328 or 30 days? (Remember the hidden-month math.)
4. 4What's charged today vs. what's charged at your maintenance dose.
5. 5Every recurring fee — membership, visits, labs, shipping, supplies.
6. 6The refill deadline (especially for high-dose Zepbound).
7. 7How to cancel, whether it's a monthly or annual commitment, and whether any prepaid amount is refundable.

State availability varies too — the provider's intake, or the coverage checkers linked above, will tell you what's available where you live.

What are the honest downsides of keeping a GLP-1 under $500?

Staying under the cap sometimes means using your own prescriber, hitting a refill deadline, prepaying for a year of care, or accepting a specific formulation. Compounded routes can free up budget but add a real FDA-status and safety question. None of these are dealbreakers — but you should choose them with your eyes open.

• Manufacturer-direct doesn't include a prescriber. Cheapest drug price, but you need your own doctor.
• High-dose Zepbound has almost no room. ~$488/month leaves about $12 before anything else.
• The 13th fill. A 28-day medicine costs one extra fill a year — roughly a full extra month's price.
• Miss the Zepbound refill window and the price can jump from $449 to $499 or $699 per fill.
• Annual prepay lowers the monthly number but raises today's charge. Great rate, bigger bill up front.
• "No subscription" care can still mean paid follow-ups — three or four Walgreens visits is $150–$200.
• Compounded programs carry a separate FDA-status question on top of the price question.
• Intro offers end. The ongoing price is what you'll pay for years, not months.

Which route fits your specific situation?

How we researched and ranked these options

We put FDA, Medicare, and manufacturer sources ahead of provider marketing and reviews. Winners are chosen by verified all-in cost and real-world fit — never by how much a provider pays us. Where we couldn't fully confirm a price at checkout, we said so instead of guessing.

Our source order, top to bottom:

1. 1FDA, Medicare/CMS, and official prescribing information
2. 2Manufacturer terms (LillyDirect, NovoCare)
3. 3Official provider pricing pages (Ro, Sesame, Walgreens)
4. 4Independent reviews — used only for service experience, not medical claims
5. 5Forums and Reddit — used only to understand how real people describe the problem

How we weigh it. Total-cost accuracy carries the most weight, then regulatory clarity, then access and continuity of care, then cancellation flexibility, then support experience. Affiliate payouts carry zero weight in what we recommend. If that sounds like a strange thing for a site with affiliate links to say — good. It's the whole point, and it's why the cheapest route on this page (buying direct) is one we earn nothing from.

Frequently asked questions about GLP-1s under $500 per month

13 questions covering pricing, insurance, Medicare, compounded GLP-1s, and more.

Can I get a GLP-1 for under $500 a month without insurance?

Yes. You don't need insurance to get a GLP-1 in 2026. Buying manufacturer-direct, an FDA-approved GLP-1 costs about $149–$449 a month depending on the drug and dose — the Wegovy pill and Foundayo start at $149, and Zepbound starts at $299 for the starter dose.

What is the cheapest FDA-approved GLP-1 for weight loss?

By cash price, the cheapest FDA-approved options are Foundayo and the Wegovy pill at $149/month for the lowest dose. The cheapest FDA-approved injection is Zepbound at $299/month for the starting dose. Your clinician decides which medicine and dose actually fit you.

Is Zepbound really $449 at every dose?

Zepbound is $299 (2.5 mg), $399 (5 mg), and $449 (7.5–15 mg) per 28-day fill through LillyDirect. The $449 price is a purchase offer that requires a refill within 45 days. Miss that window and it can rise to $499 or as high as $699 at the top doses.

Does the $449 Zepbound price include a doctor?

No. The manufacturer price is for the medication only. You either bring your own prescriber or pay a telehealth platform (like Ro) that bundles the prescriber and care into a separate fee.

Is Ro under $500 a month?

For Foundayo, the Wegovy pill, and starter-dose Zepbound, yes — those routes land roughly $273–$399 a month all-in. For ongoing higher-dose Zepbound, no — once you add the membership, it crosses $500, and buying direct is cheaper.

Why does a 28-day fill cost more than the monthly price?

Because 28 days does not divide evenly into a year. You need about 13 fills to cover 365 days, not 12. So a $449 "monthly" fill really costs about $488 a calendar month.

Are compounded GLP-1 medications FDA-approved?

No. Compounded semaglutide and tirzepatide are not FDA-approved, which means the FDA does not review them for safety, quality, or effectiveness before they are sold. They are also not the same as generic drugs, which are FDA-approved.

Is a compounded GLP-1 illegal?

It's complicated. A clinician can still prescribe a compounded version in specific, patient-specific situations when an FDA-approved drug won't meet the need. But since the FDA declared the shortages over, routinely making copies of these drugs is on shaky legal ground, and the FDA has proposed closing the last major pathway. Either way, the product isn't FDA-approved.

Can Medicare patients really get a GLP-1 for $50?

Yes, if eligible. The Medicare GLP-1 Bridge program (July 1, 2026 – December 31, 2027) offers a flat $50 copay for a one-month supply for eligible Part D members who meet the BMI and health criteria, covering Wegovy (injection and tablets), Foundayo tablets, and the Zepbound KwikPen.

Can I use HSA or FSA funds?

Maybe — but don't assume. Some manufacturer self-pay offers restrict reimbursement through health accounts, and a care fee may be treated differently than the medication. Check the specific program's terms and your plan administrator before counting on it.

Do taxes and shipping count toward the $500 cap?

Yes. Every mandatory charge counts — medication, membership, visits, labs, shipping, supplies, and taxes — because those are what actually hit your card.

Is Ozempic under $500 without insurance?

Through NovoCare's cash program, Ozempic runs about $349/month for the 0.25–1 mg doses and $499/month for the 2 mg dose, which fails the cap once normalized. Note that Ozempic is FDA-approved for type 2 diabetes, not weight loss — Wegovy and Zepbound are the GLP-1s approved for weight management.

What happens after the introductory price ends?

Your cost rises to the ongoing rate, and it can climb as your dose increases. Always confirm the maintenance price — the price at the dose you'll actually settle on — not just the first-month teaser.

What expires and when (so you're not caught off guard)

Prices in this space move fast. Here's what to re-check and when:

Next scheduled price review: August 1, 2026. We re-verify monthly and update the date at the top of this page.